The Scleroderma Foundation has awarded eight research grants for projects seeking to advance personalized medicine, lab-grown skin, new therapeutic…
Articles by Forest Ray PhD
Low levels of the galectin-10 protein (Gal-10) in scleroderma patients associate with inflammation and vascular changes in the lungs, leading…
The Anna Belle Carter Memorial Foundation (ABCMF) is offering scholarships to students living with scleroderma and their siblings…
The two COVID-19 vaccines that recently received emergency approval from the U.S. and other worldwide regulatory agencies are expected…
The U. S. Food and Drug Administration (FDA) has granted orphan drug designation to ACE-1334, an investigational therapy…
Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography…
Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the…
People with scleroderma who lack disease-related autoantibodies show a clinically distinct profile, which includes younger age at disease onset,…
Pneumonia and sepsis are the most common serious infections among scleroderma patients needing hospitalization in the U.S., a study…
The first patients have been dosed in a Phase 2a clinical trial of EHP-101,…